ScripAtai Life Sciences of Germany’s proposed acquisition of private UK firm Beckley Psytech to create a psychedelic mental health powerhouse at a time when US regulators and politicians are sending encour
ScripThe list of companies that have made money out of a gene therapy is extremely short but Ferring Pharmaceuticals has a case for inclusion given the sales growth last year of its bladder cancer treatmen
Pink SheetThe novel candidates under US Food and Drug Administration review in oncology and neuroscience, its two biggest pending therapy areas, highlight the deep inroads precision medicine has made in contemp
ScripCG Oncology believes that the Phase III data for its oncolytic immunotherapy for bladder cancer show that cretostimogene grenadenorepvec can spare patients bladder surgery, and analysts said the data